We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
-1.3%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.7B
AUM Growth
-$92.8M
Cap. Flow
-$38.9M
Cap. Flow %
-2.28%
Top 10 Hldgs %
46.62%
Holding
47
New
2
Increased
10
Reduced
25
Closed
5

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$42.9M
2
KOS icon
Kosmos Energy
KOS
+$37.7M
3
PPLI
People Inc
PPLI
+$34.6M
4
DXC icon
DXC Technology
DXC
+$25.1M
5
C icon
Citigroup
C
+$16.5M

Top Sells

Rank Stock Value
1
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$41.8M
2
TMHC
Taylor Morrison
TMHC
+$29M
3
OVV icon
Ovintiv
OVV
+$25.6M
4
UBER icon
Uber
UBER
+$21.9M
5
SPLK
Splunk Inc
SPLK
+$16.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 32.1%
2 Financials 23.01%
3 Communication Services 11.94%
4 Energy 10.92%
5 Technology 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
26
Fiserv Inc
FISV
$27.5B
$30.6M 1.79%
270,626
-18,983
-7% -$2.34M
KRTX
27
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$29.8M 1.75%
176,252
-574
-0.3% -$108K
SOFI icon
28
SoFi Technologies
SOFI
$23.4B
$29.8M 1.75%
3,728,538
-707,326
-16% -$6.22M
EXE
29
Expand Energy Corp
EXE
$21.7B
$27.5M 1.61%
318,745
-182,090
-36% -$15.5M
DXC icon
30
DXC Technology
DXC
$1.74B
$25M 1.46%
1,198,173
+1,095,323
+1,065% +$25.1M
PTON icon
31
Peloton Interactive
PTON
$2.39B
$23.6M 1.38%
4,668,814
+1,851,286
+66% +$13.2M
WAL icon
32
Western Alliance Bancorporation
WAL
$8.92B
$21.1M 1.24%
458,355
+16,948
+4% +$800K
CLF icon
33
Cleveland-Cliffs
CLF
$7B
$20M 1.18%
1,281,694
-709,613
-36% -$11.1M
PGEN icon
34
Precigen
PGEN
$2.53B
$19.5M 1.15%
13,753,176
+2,509,616
+22% +$3.56M
RKT icon
35
Rocket Companies
RKT
$38.1B
$3.24M 0.19%
396,677
-95,923
-19% -$970K
FANG icon
36
Diamondback Energy
FANG
$52.8B
$1.55M 0.09%
10,000
– –
LEN.B icon
37
Lennar Class B
LEN.B
$20.5B
$1.28M 0.08%
13,150
– –
TEVA icon
38
Teva Pharmaceuticals
TEVA
$40.9B
$1.27M 0.07%
125,000
-181,054
-59% -$1.69M
VNT icon
39
Vontier
VNT
$4.96B
$1.24M 0.07%
40,000
– –
BRLT icon
40
Brilliant Earth
BRLT
$20.5M
$738K 0.04%
250,000
+198,632
+387% +$713K
ADT icon
41
ADT
ADT
$5.57B
– –
-100,000
Closed -$603K
BAC icon
42
Bank of America
BAC
$440B
– –
-25,000
Closed -$717K
SFIX
43
Stitch Fix
SFIX
$554M
– –
-856,900
Closed -$3.3M
TMHC
44
DELISTED
Taylor Morrison
TMHC
– –
-594,402
Closed -$29M
FTCH
45
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-6,916,449
Closed -$41.8M
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Patient Capital Management held 47 positions worth $1.7B, down 5.2% from $1.8B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Patient Capital Management's Q3 2023 filing shows 2 new, 10 increased, 25 reduced and 5 closed positions. Its largest new stake was CVS Health: 605,120 shares worth $42.2M. The largest sale was Farfetch Limited Class A Ordinary Shares, an estimated $41.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, down from 34% a quarter earlier, followed by Financials and Communication Services.

  • Patient Capital Management's largest Q3 2023 buy was CVS Health: 605,120 shares worth $42.2M.
  • Patient Capital Management added most to People Inc in Q3 2023, an estimated $34.6M increase.
  • Patient Capital Management's biggest Q3 2023 reduction was Ovintiv, cutting an estimated $25.6M.
  • Patient Capital Management fully exited Farfetch Limited Class A Ordinary Shares in Q3 2023, selling an estimated $41.8M.
  • Patient Capital Management's ten largest holdings make up 47% of its $1.7B portfolio in Q3 2023.
  • Patient Capital Management opened 2 new positions and closed 5 in Q3 2023.
  • Patient Capital Management's portfolio value fell 5.2% quarter-over-quarter to $1.7B.

Based on Patient Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.